We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Antidepressant Use by Class: Association with Major Adverse Cardiac Events in Patients with Coronary Artery Disease.
- Authors
Grace, Sherry L.; Medina-Inojosa, Jose R.; Thomas, Randal J.; Krause, Heather; Vickers-Douglas, Kristin S.; Palmer, Brian A.; Lopez-Jimenez, Francisco
- Abstract
<bold>Background: </bold>To assess use of antidepressants by class in relation to cardiology practice recommendations, and the association of antidepressant use with the occurrence of major adverse cardiovascular events (MACE) including death.<bold>Methods: </bold>This is a historical cohort study of all patients who completed cardiac rehabilitation (CR) between 2002 and 2012 in a major CR center. Participants completed the Patient Health Questionnaire (PHQ-9) at the start and end of the program. A linkage system enabled ascertainment of antidepressant use and MACE through 2014.<bold>Results: </bold>There were 1,694 CR participants, 1,266 (74.7%) of whom completed the PHQ-9 after the program. Depressive symptoms decreased significantly from pre- (4.98 ± 5.20) to postprogram (3.57 ± 4.43) (p < 0.001). Overall, 433 (34.2%) participants were on antidepressants, most often selective serotonin reuptake inhibitors (SSRI; n = 299; 23.6%). The proportion of days covered was approximately 70% for all 4 major antidepressant classes; discontinuation rates ranged from 37.3% for tricyclics to 53.2% for serotonin-norepinephrine reuptake inhibitors (SNRI). Antidepressant use was significantly associated with lower depressive symptoms after CR (before, 7.33 ± 5.94 vs. after, 4.69 ± 4.87; p < 0.001). After a median follow-up of 4.7 years, 264 (20.9%) participants had a MACE. After propensity matching based on pre-CR depressive symptoms among other variables, participants taking tricyclics had significantly more MACE than those not taking tricyclics (HR = 2.46; 95% CI 1.37-4.42), as well as those taking atypicals versus not (HR = 1.59; 95% CI 1.05-2.41) and those on SSRI (HR = 1.45; 95% CI 1.07-1.97). There was no increased risk with use of SNRI (HR = 0.89; 95% CI 0.43-1.82).<bold>Conclusion: </bold>The use of antidepressants was associated with lower depression, but the use of all antidepressants except SNRI was associated with more adverse events.
- Subjects
CORONARY disease; ANTIDEPRESSANTS; CORONARY heart disease treatment; DRUG side effects; CARDIAC rehabilitation; NORADRENALINE; PATIENTS; THERAPEUTICS; SEROTONIN uptake inhibitors; MENTAL depression; LONGITUDINAL method; QUESTIONNAIRES; RESEARCH funding; RELATIVE medical risk
- Publication
Psychotherapy & Psychosomatics, 2018, Vol 87, Issue 2, p85
- ISSN
0033-3190
- Publication type
journal article
- DOI
10.1159/000486794